TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature

TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature

BackgroundTAFRO syndrome has been reported in Japan among human herpesvirus 8 (HHV-8)-negative/idiopathic multicentric Castleman’s disease (iMCD) patients. To date, the majority of iMCD patients with TAFRO syndrome originate from Japan.Case presentationHerein, we report a 67-year-old HIV/HHV-8-negat...

Full description

Bibliographic Details
Main Authors:	Céline Louis, Sandrine Vijgen, Kaveh Samii, Yves Chalandon, Louis Terriou, David Launay, David C. Fajgenbaum, Jörg D. Seebach, Yannick D. Muller
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-09-01
Series:	Frontiers in Medicine
Subjects:	TAFRO Caucasian review of literature Castleman–Kojima disease multicentric Castleman’s disease
Online Access:	http://journal.frontiersin.org/article/10.3389/fmed.2017.00149/full

Similar Items

TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy
by: Corinne Williams, et al.
Published: (2021-09-01)

Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review
by: Amélie Leurs, et al.
Published: (2019-06-01)

A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease
by: Alexandra Butzmann, et al.
Published: (2021-03-01)

A Rare Variant of Idiopathic Multicentric Castleman Disease: TAFRO Syndrome
by: Ece Ük, et al.
Published: (2022-08-01)

Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysis
by: Yoshito Nishimura, et al.
Published: (2022-08-01)

TAFRO syndrome presenting as intrahepatic cholangitis on autopsy
by: Hiroaki Nishioka, et al.
Published: (2021-04-01)

TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
by: Kazue Takai
Published: (2024-03-01)

TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities
by: Kun-Hua Tu, et al.
Published: (2021-06-01)

The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report
by: Yu Fujiwara, et al.
Published: (2018-10-01)

Epstein–Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab
by: Seiji Kakiuchi, et al.
Published: (2023-01-01)

Concurrent HIV viral blips during two episodes of multicentric Castleman disease in an adult on antiretroviral therapy: Implication for HIV persistence
by: Ilyse Darwish, et al.
Published: (2021-01-01)

Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with Trichosporon asahii infection in the lungs and myocardial infarction: an autopsy case report and literature review
by: Arata Hibi, et al.
Published: (2018-04-01)

Histopathologic findings of TAFRO syndrome with immunohistochemical analysis of the kidney specimen: A case report
by: Taiki Sato, et al.
Published: (2021-03-01)

Variant of plasmablastic microlymphoma in Castleman disease: a case report and review of the literature
by: Nathan Artom, et al.
Published: (2018-12-01)

Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 Vaccine
by: Christian Hoffmann, et al.
Published: (2022-10-01)

A rare HIV-associated hyaline vascular multicentric castleman disease with good early response to single-agent rituximab: A case from Tanzania
by: William Frank Mawalla, et al.
Published: (2022-11-01)

Treatment and Outcome of Castleman Disease: A Retrospective Report of 31 Patients
by: Tang D, et al.
Published: (2022-04-01)

Castleman Disease: A Multicenter Case Series from Turkey
by: Eren Gündüz, et al.
Published: (2022-05-01)

Cutaneous plasmacytosis: A rare initial presentation of idiopathic multicentric Castleman's disease
by: Yu Yamamoto, et al.
Published: (2021-05-01)

General anesthesia in a patient with multicentric Castleman's disease: a case report
by: Hee Won Son, et al.
Published: (2015-06-01)

Hyaline Vascular Type of Unicentric Castleman Disease in a Kidney with End-Stage Renal Disease: A Case Report of a Rare Entity at an Unusual Location and a Special Clinical Setting
by: Chuan-Han Chen, et al.
Published: (2022-11-01)

Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease
by: Asami Nishikori, et al.
Published: (2022-09-01)

Prevalence of Castleman's disease in patients suffering from cervical lymphadenopathy
by: Michael Krokenberger, et al.
Published: (2022-10-01)

TAFRO syndrome: current perspectives
by: Sakashita K, et al.
Published: (2018-01-01)

Idiopathic multicentric Castleman’s disease
by: V. I. Vasilyev, et al.
Published: (2020-06-01)

A Rare Association between Idiopathic Multicentric Castleman Disease, Nephrotic Syndrome and Polyneuropathy in an immunocompetent patient
by: Luís Landeiro, et al.
Published: (2021-10-01)

Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences
by: Bernardo Rossini, et al.
Published: (2024-03-01)

Multicentric vs. Unresectable Unicentric Castleman Disease with Active Presentation: An Orphan Rare Disease in a Young Egyptian Female Patient. A Case Report
by: Yasmine Shaaban, et al.
Published: (2023-06-01)

TAFRO syndrome was effectively treated with an inexpensive novel scheme: A case report
by: Shan Meng, et al.
Published: (2023-02-01)

Multicentric Castleman disease with TAFRO syndrome and Sjögren's
by: Zi Ying Li, et al.
Published: (2019-12-01)

Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi
by: Matthew S. Painschab, et al.
Published: (2022-12-01)

Acute polyarticular synovitis as a rare presentation of Kaposi sarcoma
by: Larissa Larsen, et al.
Published: (2014-01-01)

Lenalidomideas a Second-line Therapy Achieves Long-term Remission in Elderly Patients with Relapsed/Refractory Multicentric Castleman's Disease：a Report of Two Cases and Literature Review
by: TANG Yangming, SHI Renzhou, LAN Mei, LI Xuejun, WEN Zonghua, LU Xiaochen
Published: (2022-01-01)

MIXED HYALINE VASCULAR AND PLASMA CELL TYPE CASTLEMAN’S DISEASE: REPORT OF A CASE
by: F. Asgarani, et al.
Published: (2006-02-01)

MIXED HYALINE VASCULAR AND PLASMA CELL TYPE CASTLEMAN’S DISEASE: REPORT OF A CASE
by: F. Asgarani, et al.
Published: (2006-05-01)

Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report
by: Yu-han Gao, et al.
Published: (2024-03-01)

Transformation of HHV‐8‐negative idiopathic multicentric Castleman disease into diffuse large B‐cell lymphoma: A case report from Nepal
by: Ashwini Gupta, et al.
Published: (2023-09-01)

Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease?
by: Gavin Ha, et al.
Published: (2023-06-01)

Symptom burden in patients with idiopathic multicentric Castleman disease and its impact on daily life: an international patient and caregiver surveyResearch in context
by: Sudipto Mukherjee, et al.
Published: (2023-10-01)

Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman’s Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation
by: Giovanni Paolino, et al.
Published: (2024-04-01)